Switch to English?
Yes
Переключитись на українську?
Так
Переключиться на русскую?
Да
Przełączyć się na polską?
Tak

Dmytro Shypulin

Offer Dmytro work on your next project.

Ukraine Kyiv, Ukraine
1 month 11 days back
Temporarily not working temporarily not working
age 50 years
on the service 1 month 23 days

    Rating

    Successful projects
    No data
    Average rating
    No data
    Rating
    332
    Copywriting
    645 place out of 9124
    Articles & Blog Posts
    275 place out of 3268

    Language proficiency level

    Українська Українська: fluent
    Русский Русский: fluent
    English English: pre-intermediate
    Deutsch Deutsch: pre-intermediate

    Skills and abilities

    Portfolio


    • 13 USD

      Type 2 diabetes: from insulin resistance to management

      Copywriting
      Introduction
      Type 2 diabetes mellitus (T2DM) has ceased to be merely a "high sugar disease." Today, it is regarded as a multifactorial metabolic disorder that leads to systemic vascular damage and premature aging of the body. Modern endocrinology focuses on the concept of early intensification of therapy to achieve the effect of "metabolic memory," which allows for a radical reduction in the risk of cardiovascular catastrophes.
      1. Etiopathogenesis: the role of insulin resistance
      At the core of T2DM are complex mechanisms known as the "ominous octet":
      Insulin resistance (IR): decreased sensitivity of the liver, muscles, and adipose tissue to insulin, which blocks glucose utilization.
      β-cell dysfunction: gradual exhaustion of the pancreas, which loses the ability for adequate hormone secretion.
      Incretin deficiency: impaired secretion of GLP-1, leading to loss of control over appetite and postprandial (after meal) glycemia.
      2. Diagnostic markers and target indicators
      Effective diabetes management is impossible without regular monitoring:
      Glycated hemoglobin (HbA1c): an integral indicator over the last 3 months (target level for most adults).
    • 16 USD

      Arterial hypertension: Modern paradigm of diagnosis, stratification

      Copywriting
      Introduction
      Arterial hypertension (AH) remains a leading modifiable risk factor for cardiovascular morbidity and premature mortality on a global scale. According to the current ESC/ESH (European Society of Cardiology and Hypertension) guidelines, the approach to treatment has shifted from simply lowering blood pressure (BP) numbers to comprehensive management of cardiovascular risk and protection of target organs.
      1. Etiopathogenesis: Multifactorial Mechanism
      The development of hypertensive disease (essential AH) is considered a result of a complex interaction between genetic polymorphism and exogenous triggers:
      Neurohumoral dysregulation: Persistent hyperactivation of the renin-angiotensin-aldosterone system (RAAS) and sympathetic-adrenal system (SAS).
      Endothelial dysfunction: Disruption of the balance between vasodilating (NO, prostacyclin) and vasoconstricting (endothelin-1) factors.
      Metabolic component: The interrelationship between hyperinsulinemia and the natriuretic function of the kidneys, leading to volume overload.
      Structural remodeling: Proliferation of smooth muscle cells in the vascular wall, increasing total peripheral vascular resistance (TPVR).
      2. Modern Classification and Diagnostic Criteria
      According to protocols, the diagnosis of AH is established with a stable increase in office BP ≥140/90 mmHg. An important step is classification by degrees:
      Grade I: 140–159 / 90–99 mmHg.
      Grade II: 160–179 / 100–109 mmHg.
      Grade III: ≥180 / ≥110 mmHg.
      A key aspect: Assessment of target organ damage (TOD), particularly the detection of left ventricular hypertrophy (LVH), microalbuminuria, and changes in the fundus, is crucial for determining the patient's prognosis.
      3. Pharmacotherapeutic Strategy: Evidence Base
      The modern tactic involves early initiation of combination therapy (often in the form of fixed combinations — Single Pill Combination) to improve patient adherence to treatment (compliance).
      Main classes of drugs:
      RAAS blockers (ACE inhibitors and ARBs): Provide significant organ protection (nephro- and cardioprotection).
      Calcium antagonists (CA): Dihydropyridine derivatives (amlodipine, lerkanidipine) have a powerful vasodilating effect and metabolic neutrality.
      Thiazide-like diuretics: Effective for controlling volume status, especially in elderly patients.
      β-blockers: Prescribed in the presence of specific indications (IHD, chronic heart failure, heart rate control).
      4. Non-pharmacological Correction and Lifestyle Modification
      The effectiveness of therapy directly depends on lifestyle correction:
      Diet therapy: Implementation of the DASH protocol (Dietary Approaches to Stop Hypertension), sodium restriction to
    • 13 USD

      Joint pain: causes, pathogenesis, and modern approaches to treatment

      Copywriting
      Joint pain (arthralgia) is one of the most common reasons for patients to visit a doctor. It can be acute or chronic and is often a manifestation of both local and systemic diseases.

      ---

      Main causes of arthralgia
      1. Degenerative-dystrophic diseases
      - Osteoarthritis is the most common cause of chronic pain, accompanied by cartilage destruction and changes in the bones.
      2. Inflammatory processes
      - Rheumatoid arthritis, gout, psoriatic arthritis - active inflammation, pain at rest, morning stiffness.
      3. Traumatic injuries
      - Acute injuries or chronic overloads.
      4. Metabolic disorders
      - Disorders of uric acid metabolism, vitamin D deficiency.
      5. Infectious factors
      - Reactive arthritis following infections.

      ---

      Pathogenesis
      - activation of prostaglandins and cytokines;
      - degradation of cartilage tissue;
      - changes in the synovial membrane;
      - disruption of joint biomechanics.

      ---

      Clinical manifestations
      - pain during movement, loading, or at rest;
      - morning stiffness;
      - limited mobility;
      - swelling, local temperature increase;
      - skin redness;
      - crepitus (crackling);
      - joint deformation;
      - general symptoms (weakness, subfebrile temperature).

      ---

      Modern approaches to treatment
      Pharmacotherapy:
      - NSAIDs (ibuprofen, diclofenac, naproxen, meloxicam)
      - Analgesics (paracetamol)
      - Glucocorticosteroids (as indicated)
      - Chondroprotectors (glucosamine, chondroitin)

      Symptomatic agents:
      - local gels and ointments (diclofenac, ketoprofen)
      - analgesic patches
      - muscle relaxants
      - drugs to improve microcirculation

      Intra-articular injections:
      - glucocorticosteroids
      - hyaluronic acid
      - PRP therapy
      - chondroprotectors

      Non-drug methods:
      - therapeutic exercise
      - physiotherapy
      - weight control
      - orthopedic devices

      ---

      Prevention
      - regular physical activity;
      - weight control;
      - balanced nutrition;
      - avoiding overloads;
      - timely treatment of concomitant diseases.

      ---

      Conclusion
      Joint pain requires a comprehensive approach. Timely diagnosis and appropriately selected treatment can reduce symptoms and improve the quality of life for the patient.

    Activity

      Latest proposals 4
    FAQ section (Steroids / Bodybuilding)
    601 USD
    Daily data Entry -copy paste job
    50 USD
    Data Entry – Copy/Paste job
    50 USD
    Scriptwriter for advertising creatives (Facebook/Tik-Tok Ads)
    111 USD